Guangzhou Baiy | 600332 - Operating Expenses

Stock Price
25.56
Daily Change
0.10 0.39%
Monthly
1.23%
Yearly
-4.70%
Q1 Forecast
24.89

Guangzhou Baiy reported CNY18.43B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Aspen Pharmacare ZAR 18.69B 1.51B Jun/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Jiangsu Hengrui CNY 5.94B 254.97M Sep/2025
Kalbe Farma IDR 8.06T 883.47B Sep/2025
Richter Gedeon HUF 151.11B 1.91B Sep/2025
Sh Fosun Pharma CNY 9.12B 194.06M Sep/2025
Sh Pharmaceutical CNY 71.66B 3.34B Sep/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025